Supplementary Material for: Metabolic and bariatric surgery in adolescents: a single-center study of efficacy and outcome predictors by Beck R.H. (20498033)

“…There was a significant increase (p=0.02) in HDL cholesterol and a significant decrease in triglycerides (p=0.0001) and ALT (p=0.0004) after surgery. …”

Table 1_Elevated CO2 decreases micronutrient Zn but not Fe in vegetables – evidence from a meta-analysis.docx by Xiaolin Wang (303612)

Model-averaged coefficients, significance, and relative importance (RI) of the predictor variables for the GLMMs to evaluate effects on: (A) overall pollinator abundance; (B) fruit... by Carmelo Gómez-Martínez (9384385)

Table 1_Fertilization decreases the effect of ammonium nitrogen on microorganisms in Chinese Carex tibetikobresia meadows during rest-grazing.docx by Xuanbo Zhou (19374205)

Data from: <b>Selection and genetic variation in plasticity drive age-related decreases in among-individual behavioural correlations</b> by Chang Seok Han (21814121)

“…Our findings indicate that the magnitudes of both the positive among-individual and genetic correlations were maintained across nymph and young adult stages, but significantly decreased with age during adulthood. This decrease was due to both selection and genetic variation in age-related behavioural plasticity. …”

Data Sheet 1_A synonymous mutation of rs1137070 cause the mice Maoa gene transcription and translation to decrease.pdf by Kai Xin Li (19696741)

Data Sheet 1_Dihydroartemisinin decreases pre-existing neutralizing antibodies against adeno-associated virus in challenged mice.pdf by Jingjing Fang (124938)

Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”

Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”

Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

“…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. We hypothesize that the addition of ruxolitinib to UCB-Tregs may improve SLE outcomes.…”

Study imaging parameter descriptions and measurements (median). by Harshit Arora (22008280)

Subjects:

Relationship of cord compression subtype with neurologic recovery over the first year after tSCI. by Harshit Arora (22008280)

Subjects:

Area under the ROC Curve (AUC) analysis to predict AIS conversion at 6-months and 1-year following acute cervical tSCI. by Harshit Arora (22008280)

Subjects:

Area under the ROC curve (AUC) analysis to predict neurological severity at 6-months and 1-year following acute cervical tSCI. by Harshit Arora (22008280)

Subjects:

Spearman correlations between the various baseline radiological parameters. by Harshit Arora (22008280)

Subjects:

Follow-up for individuals with acute cervical tSCI (n = 103). by Harshit Arora (22008280)

Subjects:

STROBE Flow Diagram Describing Study Cohort Selection. by Harshit Arora (22008280)

Subjects:

Artwork demonstrating the principal tSCI compression subtypes. by Harshit Arora (22008280)

Subjects:

Baseline demographic and clinical characteristics of individuals admitted with cervical tSCIs (n = 169). by Harshit Arora (22008280)

Subjects:

Table 1_Higher oxidative balance score is associated with a decreased risk of infertility: an analysis of NHANES 2013–2020.docx by Mingjun Ma (11518765)